Clinical trial · Observational
International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients
Pilot Survey to Assess International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients at Memorial Sloan-Kettering Cancer Center
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel. Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| questionnaires | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- questionnaires
- description
- There will be four versions of the questionnaire, each slightly modified to be more specific toward the treatment paradigms in the respective target patient population (Breast Cancer/ Lymphoma/Autologous Bone Marrow Transplant/ Allogeneic Bone Marrow Transplant). All questionnaire versions will consist of seven sections.
- interventionNames
- Behavioral: questionnaires
Primary outcomes (1)
- measure
- To determine the frequency of international travel of the targeted patients in the last 5 years.
- timeFrame
- once at the time of the clinic visit
Secondary outcomes (4)
- measure
- To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised.
- timeFrame
- once at the time of the clinic visit
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Hematopoietic Stem Cell Transplant (HSCT) recipients * Age \>18 years * Status post bone marrow transplant within last five years Breast Cancer patients: Criteria 1 and Criteria 2 and/or 3 * Female age \>18 years and current or past history of breast cancer * Received systemic chemotherapy in the last five years * Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3 * Age \>18 years and current or past history of lymphoma * Received systemic chemotherapy within 5 years * Had active disease at any time within the last 5 years Exclusion Criteria: * Patients age\< 18 years * Breast cancer and lymphoma patients in clinical remission in the past 5 years * Patients unable to fill the questionnaire due to language barriers
References
Publications (0)
Data not yet available